Table 1 Clinical data of 50 PCa patients analyzed by IHC using conventional paraffin slides with regard to TET1 expression (n = 50 patients in total)
Count (%) | Age (y) | PSA (ng/mL) | |||
|---|---|---|---|---|---|
Median | Range | Median | Range | ||
T2a–c | 26 (52.0%) | 64.24 | 47.8–75.1 | 7.0 | 0.1–54.8 |
T3a–b | 24 (48.0%) | 64.16 | 55.5–74.9 | 9.0 | 0.6–27.2 |
GS6 | 23 (46.0%) | 65.88 | 47.8–75.1 | 8.8 | 0.1–24.8 |
GS7 | 20 (40.0%) | 63.93 | 54.8–73.1 | 8.8 | 0.8–54.8 |
GS8 | 2 (4.0%) | 65.53 | 58.2–72.8 | 6.0 | 2.7–9.3 |
GS9 | 5 (10.0%) | 65.20 | 55.5–74.9 | 14.1 | 6–22.1 |